FIG. 2.

Mean ± SD concentrations of foscarnet in plasma following oral administration (day 1 [n = 6; □] and day 8 [n = 4; ▪] of dosing with 90 mg/kg BID). Intravenous (iv) foscarnet (90 mg/kg) was infused over a 2-h period (——), [n = 4]). Two of the six patients in this group withdrew from the study and were unavailable for investigations on day 8 and for intravenous dosing.